Tag: pta
WAVE trial six-month data show “tremendous” results for WRAPSODY
The six-month results of the WAVE (WRAPSODY Arteriovenous Access Efficacy) pivotal trial have reported superior target lesion primary patency (TLPP) with the WRAPSODY (Merit...
DCB vs plain balloon AV access angioplasty: More investigation is needed,...
At the recent Cardiovascular and Interventional Radiological Society of Europe (CIRSE) annual meeting (14–18 September, Lisbon, Portugal), Kate Steiner (East and North Herts NHS...
Merit Medical to present six-month outcomes from randomised arm of WRAPSODY...
Merit Medical has announced today plans to release findings from its WAVE study. A pivotal, international, multicentre trial, the WAVE study examines the safety...
VentureMed completes enrolment of the FLEX vessel prep system FLEX first...
VentureMed Group have announced this week that it has completed enrolment of the FLEX First arteriovenous (AV) Registry, which was designed to treat subjects...
AVeNEW trial shows superior AVF target lesion patency with covered stent...
“Study design is critically important when interpreting outcomes,” said Bart Dolmatch (Mountain View Hospital, Mountain View, USA) in his evaluation of the “disconnect” between...
Transit Scientific announces US FDA clearance for XO RX angioplasty platform
Transit Scientific has announced that the XO RX 2.2Fr and XO RX 3.8Fr platform has received US Food and Drug Administration (FDA) clearance to...
Continued clinical success reported with cutting-edge vessel prep device
Transit Scientific had shared via press release successful outcomes on multiple fistula and graft cases using its XO Score sheath platform, a first-of-its-kind metal-alloy...
Plain balloon first and drug-eluting balloon second? The role of DCBs...
Kate Steiner (Stevenage, UK) discusses existing clinical evidence on drug-coated balloons (DCBs) in the treatment of arteriovenous access stenosis—and outlines areas where further data...
IN.PACT AV DCB “first and only” to show sustained and superior...
Medtronic has announced new randomised controlled data demonstrating the sustained and superior performance of the IN.PACT AV drug-coated balloon (DCB) compared to percutaneous transluminal...
Nipro to bring Cronus high-pressure PTA balloon catheter to USA
Nipro Medical Corporation is set to introduce its second-generation Cronus high-pressure (HP) percutaneous transluminal angioplasty (PTA) balloon catheter to the US market.
Cronus HP is...
New England Journal Of Medicine publishes “outstanding” six-month IN.PACT AV Access™...
NOTE: This video is ONLY available to watch in selected countries and geographies
Robert Lookstein (New York, USA; principal investigator) and Andrew Holden (Auckland,...